Screener
Altimmune ALT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Altimmune in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Altimmune’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326190-26-000040
FAQ
- What is Altimmune's shares (diluted)?
- Altimmune (ALT) reported shares (diluted) of 124.5M in Q1 2026.
- How has Altimmune's shares (diluted) changed year-over-year?
- Altimmune's shares (diluted) increased by 64.7% year-over-year, from 75.5M to 124.5M.
- What is the long-term trend for Altimmune's shares (diluted)?
- Over 4 years (2021 to 2025), Altimmune's shares (diluted) has grown at a 19.7% compound annual growth rate (CAGR), from 162.9M to 334.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Altimmune's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude